Quantcast

Latest Amines Stories

Prescription Pain Killer Deaths Outnumber Heroin, Cocaine Overdoses
2014-06-18 07:35:39

Rebekah Eliason for redOrbit.com – Your Universe Online Reports from a new study at McGill University indicate that there are a greater number of deaths from commonly prescribed painkillers than from heroin and cocaine overdose combined. This study is the first of its kind and highlights a huge public health issue. Death from prescribed painkillers has dramatically increased in recent years with 16,000 US deaths in 2010. In per capita opioid consumption, the United States and Canada...

2014-06-17 13:13:51

American Society of Anesthesiologists Fast-acting ketamine by-product may be future therapy for Alzheimer's, Parkinson's There is new hope for people suffering from depression. Researchers have identified a compound, hydroxynorketamine (HNK), that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study in the July issue of Anesthesiology, the official medical journal of...

2014-06-17 08:30:31

Takeda and Lundbeck Announce Results at American Society of Clinical Psychopharmacology Annual Meeting HOLLYWOOD, Fla., June 17, 2014 /PRNewswire/ -- Takeda Pharmaceuticals Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced that the companies will present results about sexual functioning from a head-to-head study of Brintellix(®) (vortioxetine) vs. escitalopram in patients with well treated major depressive disorder (MDD) experiencing treatment-emergent sexual...

2014-06-16 08:27:58

Relmada Therapeutics and Camp Nine Expect Offering Proceeds to Enable It to Achieve Significant Milestones While Advancing It's Drug Development Pipeline NEW YORK, June 16, 2014 /PRNewswire/ -- Camp Nine, Inc. (the "Company"), which conducts its operations through Relmada Therapeutics Inc. ("Relmada") (OTCBB: CMPE), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it has completed equity capital raises totaling gross proceeds...

2014-06-16 08:27:34

Takeda and Lundbeck to Present Late-breaker at International College of Neuropsychopharmacology World Congress VANCOUVER, British Columbia, June 16, 2014 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced results from CONNECT, a new study that evaluated the effect of Brintellix 10-20 mg/d on aspects of cognitive function, using an objective neuropsychological test (the Digit Symbol Substitution Test or DSST) associated with executive...

2014-06-12 16:25:56

BOCA RATON, Fla., June 12, 2014 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Duloxetine Delayed-release Capsules. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by its parent company, Laboratorios Dr. Esteve, S.A. Barcelona, Spain, and will be available in 20mg, 30mg and 60mg strengths. Duloxetine Delayed-release Capsules are AB rated to...

2014-06-09 16:25:29

EMERYVILLE, Calif., June 9, 2014 /PRNewswire/ -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), today announced that the United States Patent and Trademark Office (USPTO) issued US Patent No. 8,741,343 entitled "Method Of Administering Amantadine Prior To A Sleep Period." The claims of this patent are directed towards administration, prior to bedtime, of certain formulations of amantadine HCl, including Adamas' lead product ADS-5102 and similar amantadine-based products. "This is the...

2014-06-04 12:30:20

PORTLAND, Ore., June 4, 2014 /PRNewswire/ -- Paragon BioTeck, Inc., a privately held U.S. biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, announces its FDA approved Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent, to dilate the pupil, is readily available through Bausch + Lomb or your primary wholesaler. "Paragon is committed to working proactively with the FDA in an effort to prevent disrupting...

2014-06-03 08:32:59

CHARLOTTE, N.C., June 3, 2014 /PRNewswire/ -- The Carolina Men's Clinic (http://thecarolinamensclinic.com/) was established in order to provide men of all ages a means to receive discreet, relatable treatment to resolve their most intimate, physical issues. Contrary to popular belief, clinics like the Carolina Men's Clinic are frequented by men from all walks of life. Typically, the average client is a man who is struggling with issues such as the lack of physical energy, emotional...

2014-05-30 08:25:01

- 7 total abstracts accepted for afatinib and other compounds from the company's oncology research program RIDGEFIELD, Conn., May 30, 2014 /PRNewswire/ -- Boehringer Ingelheim today announced that new data will be presented from 7 abstracts for Gilotrif® (afatinib) and investigational compounds, including nintedanib and BI 836845, from its oncology pipeline at the 50(th) Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL, on May 30 - June 3, 2014. Data include...


Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related